Breaking News

inVentiv Health Names Clinical Ops EVP

December 18, 2012

Stansfield to lead development in Europe, Asia-Pac, and Latin America

Dr. Susan C. Stansfield has joined PharmaNet/i3, inVentiv Health’s clinical segment, as executive vice president of Clinical Operations for Phase II-IV Development in Europe, Middle East, and Africa (EMEA), Asia-Pacific, and Latin America. 
 
Dr. Stansfield has successfully held senior leadership positions at other global clinical research organizations and has a proven record of significantly enhancing clinical operations.
 
“This appointment demonstrates PharmaNet/i3’s commitment to enhancing support for regional operations in parallel to our global cross-functional project management team,” said Dr. Robert M. Reekie, chief operating officer, Phase II-IV Development. “We believe Susan is a great addition to our talented global team that is focused on delivering the best possible service to our clients.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks